Yong Xiao Wang
Albany Medical College USA
University of Virginia USA
Hwa Mu Lee
Western University Health Science USA
Schoen Klinik Berchtesgadener Land Germany
Biophilia Institute Japan
Department of Health & Family Welfare India
Ram Manohar Lohia Hospital India
Institute of Tropical Medicine Nigeria
Recommended Global Pulmonology Conferences
Conference Series Ltd is overwhelmed to announce the commencement of 9th International Conference on COPD and Lungs” to be held during March 11-12, 2019 in Singapore. The upcoming conference will be organized around the theme "Every breath counts: Halt the rise of COPD".
Conference Series Ltd organizes 1000+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
COPD 2019 conference brings together individuals who have an interest in the field of Respiratory and Pulmonary Disease relating to diversified topics like COPD, emphysema, asthma, cystic fibrosis, lung cancer, other pulmonary diseases and therapeutics. It is a forum to explore issues of mutual concern as well as exchange knowledge, share evidence and ideas, and generate solutions.
This event is suited to anyone with an academic or professional interest in COPD and its research; including Researchers, Senior scientists, Pulmonologists, Professors, Doctors, Nurses, Healthcare Professionals, Pharmacologists, Clinicians, Directors of Association and Societies, Postgraduate students and those who work in research and development of pharmaceuticals and related technology.
Why to Attend???
COPD 2019 conference is an opportunity to meet others within speciality to network and to learn the latest clinical information.
With members from around the world focused on learning about pulmonary care and its advances; this is your best opportunity to reach the largest assemblage of participants from the Respiratory community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new discoveries in the COPD treatment and diagnosis, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in the world of Respiratory care are hallmarks of this conference.
Scope and Importance:
Pulmonary health has a particular interest on the impact changes in respiratory care and the awareness is increasing every year, and therefore COPD 2019 encourages submissions from researchers based in USA, Europe and Asian countries.
The challenge of the field is to evaluate current promising interventions rigorously, address emerging issues such as synthesizing ever-increasing research findings, and develop innovative dissemination and communication strategies.
The journal invites submissions on research in COPD, including emphysema, tuberculosis, asthma, pulmonary rehabilitation, cystic fibrosis, lung cancer and topics related to respiratory health.
COPD 2019 provides a platform that helps authors to share their knowledge with a wider audience, and sustains a rapid process for submissions resulting in high quality publications. We further aim to contribute towards reducing the inequity in publications from low- and middle-income countries. Our audience is global and we intend to share research results in COPD from all parts of the world.
Sessions and Tracks
Major COPD Research Associations around Asia Pacific
COPD Patient Organization of Vietnam
COPD Patients Club Kyrgyzstan
COPD Club of Northern Thailand
Asian Pacific Society of Respirology
Chinese COPD Patient Education Organziation
Major COPD Research Associations around Globe
American Association for Respiratory Care
American College of Chest Physicians
American College of Emergency Physicians
American College of Physicians
American Lung Association
Canadian Lung Association (CLA)
• Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments
• COPD Students, Scientists, Faculty
• Medical Colleges
• COPD Associations and Societies
• Business Entrepreneurs, Pharmaceutical companies
Universities Associated with COPD 2017
Major Universities on COPD Research
Kumamoto University, Japan
Tokyo National Hospital, Japan
Okayama University, Japan
Medi7 Bentleigh, Australia
Macquarie University, Australia
Australian national university, Australia
Charles Darwin University Casoria Australia
Curtin University Bentley, Australia
Dar Al Uloom University, Saudi Arabia
Iqbal Chest Centre, Bangladesh
Imperial College London, United Kingdom
Linnaeus University, Sweden
University Of California Los Angeles, United States
Columbia University Medical Center, United States
Harvard University, United States
Global Market research on COPD
The global COPD market is estimated to currently be worth $11.3 billion, and is forecast to reach
a value of $15.6 billion by 2019. The drugs driving this growth include once-daily LABA/LAMA
fixed-dose combinations such as QVA-149, umeclidinium bromide/vilanterol and olodaterol/tiotropium.
The opportunity in the U.S. and China asthma and COPD drugs market is slated to rise from a valuation of US$13.0 bn in 2015 to be worth US$18.7 bn by 2024. If these values hold true, the market is likely to expand at a modest CAGR of 4.1% therein.
North America leads the global market for asthma &COPD drugs and devices. North America was followed by Europe in terms of market capitalization. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.
The current asthma and COPD market is primarily driven by increasing patient population. It is also growing due to factors such as price erosion and expiry of patents of leading drug brands in the market. However, it is estimated that in the next five years, the global asthma and COPD drug market is expected to grow slowly and steadfast. The COPD segment was projected to be worth USD 10,593.2 million and is expected to reach USD 12,619.8 million in 2017.
In Europe, LABA / ICS combinations and LTA (Montelukast) drugs are more popular for asthma and COPD treatment.
Top few companies in this global market:
F. Hoffmann-La Roche
Novartis and Merck
Global COPD & Asthma Devices Market, By Product
Inhalers accounted for the major market and is expected to continue its dominance till 2020
Global COPD & Asthma Devices Market, By Geography
LAMEA region would exhibit the highest CAGR of 4.9% during 2017-2020
Past Conference Report
Conference series LLC Ltd successfully hosted for "6th International conference on Chronic obstructive pulmonary disease" during May 17-18, 2018, Tokyo, Japan. COPD 2018 conference was organized around the theme "COPD Today: Clinical and Research Issues" and it was a great success where eminent keynote speakers from various reputed organizations made their resplendent presence and addressed the gathering.
COPD 2018 was marked by the attendance of Editorial Board Members of supported Journals like Journal of Pulmonary & Respiratory Medicine, Journal of Lung Diseases & Treatment and Journal of Pulmonary Medicine. Many Scientists, young and brilliant Researchers, Business Delegates and talented Student Communities representing from varies countries made this conference fruitful and productive driving the three-day event into the path of success with thought provoking keynote and plenary presentations.
6th International conference on Chronic Obstructive Pulmonary Disease covered the following scientific sessions and discussions:
Asthma and allergy
Cardiovascular Risk and COPD
Pathogenesis of COPD
Airway and Therapeutic Devices
CO-Morbidities in COPD
Management of COPD
Pulmonary diseases-Treatment and therapies
Diagnostic Evaluation of COPD
Paediatric Pulmonary, Critical care and Sleep
Epidemiology of COPD
Environmental and Occupational lung Disease
Self-Management and Prevention of COPD
COPD 2018 Organizing Committee would like to thank the Moderator of the conference.
Yong –Xiao Wang
Albany Medical College, USA
Hwa Mu Lee
Western University Health Science, USA
Department of Health & Family Welfare, India
With the feedback from the participants and supporters of COPD 2018, Conference series LLC Ltd is glad to announce 9th International Conference on COPD and Lungs (COPD 2019) during March 11-12, 2019 in Singapore. COPD 2019 will cover some of the most challenging topics and advancements in research in the fields of Pulmonary and Respiratory medicine.
Past Reports Gallery